Patents by Inventor Woan-Jen Lee

Woan-Jen Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular markers for lung and colorectal carcinomas
    Patent number: 9249465
    Abstract: Molecular markers for lung and colorectal carcinomas and methods of using them in blood sample assays are disclosed. The method comprises measuring the expression of the markers in a blood sample from a subject for detecting the presence and/or severity of lung and/or colorectal cancer, and for monitoring and/or assessing the prognosis of the subject's response to a cancer therapy. Also disclosed are kits for detecting, diagnosing, and/or monitoring lung or colorectal carcinomas.
    Type: Grant
    Filed: August 28, 2009
    Date of Patent: February 2, 2016
    Assignee: Advpharma, Inc.
    Inventors: Harn-Jing Terng, Woan-Jen Lee, Chin-Yu Chen
  • COMPOSITIONS AND METHODS OF USING CRMP-1 AND ITS FRAGMENTS FOR TREATING CANCER
    Publication number: 20100168028
    Abstract: Active fragments of hcrmp1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer and methods of using the same for treating cancer are disclosed. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. Vectors capable of expressing an hcrmp1, variants of hcrmp1, fragments of hcrmp1 and/or variants of fragments of hcrmp1 are also disclosed.
    Type: Application
    Filed: March 7, 2010
    Publication date: July 1, 2010
    Applicant: ADVPHARMA, INC.
    Inventors: HARN-JING TERNG, YI-JEN LEE, WOAN-JEN LEE
  • Compositions and methods of using CRMP-1 and its fragments for treating cancer
    Patent number: 7741464
    Abstract: The present invention discloses a method for treating cancer by using hCRMP1 and/or active fragments thereof, as well as the active fragments of hCRMP1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. A vector capable of expressing an hCRMP1, a variant of hCRMP1, a fragment of hCRMP1 or a variant of a fragment of hCRMP1 is also disclosed.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: June 22, 2010
    Assignee: Advpharma Inc.
    Inventors: Harn-Jing Terng, Yi-Jen Lee, Woan-Jen Lee
  • MOLECULAR MARKERS FOR LUNG AND COLORECTAL CARCINOMAS
    Publication number: 20100075323
    Abstract: Molecular markers for lung and colorectal carcinomas and methods of using them in blood sample assays are disclosed. The method comprises measuring the expression of the markers in a blood sample from a subject for detecting the presence and/or severity of lung and/or colorectal cancer, and for monitoring and/or assessing the prognosis of the subject's response to a cancer therapy. Also disclosed are kits for detecting, diagnosing, and/or monitoring lung or colorectal carcinomas.
    Type: Application
    Filed: August 28, 2009
    Publication date: March 25, 2010
    Applicant: AdvPHARMA, Inc.
    Inventors: Harn-Jing TERNG, Woan-Jen Lee, Chin-Yu Chen
  • Compositions and methods of using CRMP-1 and its fragments for treating cancer
    Publication number: 20080287361
    Abstract: The present invention discloses a method for treating cancer by using hCRMP1 and/or active fragments thereof, as well as the active fragments of hCRMP1 that are capable of inhibiting cell proliferation, invasive activity, and metastasis of cancer. The method can also be used prior to, or in combination with, the administration a chemotherapy agent. A vector capable of expressing an hCRMP1, a variant of hCRMP1, a fragment of hCRMP1 or a variant of a fragment of hCRMP1 is also disclosed.
    Type: Application
    Filed: March 21, 2008
    Publication date: November 20, 2008
    Inventors: Harn-Jing Terng, Yi-Jen Lee, Woan-Jen Lee